Skip to content
Regulations & Compliance

NDA (new drug application)

The formal application to the FDA requesting approval to market a new drug. Contains all clinical trial data, manufacturing details, and proposed labeling. Review takes 6–12 months.

Frequently Asked Questions

What is NDA (new drug application)?
The formal application to the FDA requesting approval to market a new drug. Contains all clinical trial data, manufacturing details, and proposed labeling. Review takes 6–12 months.
Why is NDA (new drug application) important in peptide research?
Understanding nda (new drug application) is crucial for navigating the legal and regulatory landscape of peptide use. Regulatory knowledge helps practitioners and patients distinguish between approved therapies, compounded medications, and research chemicals.

Related Terms

FDA approved

A designation indicating the U.S. Food and Drug Administration has determined a drug is safe and effective for its labeled indication based on clinical trial evidence. FDA-approved peptides include semaglutide, tirzepatide, liraglutide, and PT-141.

BLA (biologics license application)

The regulatory pathway for approval of biological products (including some peptides and proteins) by the FDA. Similar to an NDA but specifically for biologics derived from living organisms.

Phase 3 trial

Large-scale randomized controlled trials (1,000–3,000+ patients) comparing the investigational peptide to placebo or standard of care. Positive Phase 3 results are required for FDA approval.

← Back to full glossary